Abstract:Background: Cardiac injury is recognized as one of the most common critical complications during exacerbation of coronavirus disease 2019 (COVID-19). This study aimed to investigate the effect of cardiac injury on the clinical course of COVID-19 and to examine its potential mechanism and treatments.Methods and Results: A total of 222 hospitalized patients with COVID-19 from Wuhan were selected for the study during February 10 to March 28, 2020. Demographic, laboratory, and clinical data on admission and during hospitalization were compared between patients with COVID-19 with or without cardiac injury. On admission, cardiac injury (n = 29) was associated with advanced age, more underlying coronary artery disease, and a lower PaO2. Troponin levels were correlated with inflammatory markers (C-reactive protein: r = 0.348, P < 0.001; interleukin 6: r = 0.558, P < 0.001) and D-dimer levels (r = 0.598, P < 0.001). During hospitalization, another six patients suffered from cardiac injury and cardiac injury (n = 35), resulting in higher rates of ventilation (invasive: 51.4 vs. 1.6%, P < 0.001; non-invasive: 31.4 vs. 1.1%, P < 0.001) and mortality (54.3 vs. 1.1%, P < 0.001). Cardiac injury on admission was a predictive factor for mortality (adjusted hazard ratio = 4.73, 95% confidence interval = 1.35–16.63, P = 0.015). Receiver operating characteristic curve analysis showed that, on admission, a troponin level of 36.35 pg/mL was predictive for mortality with a sensitivity of 73.7% and a specificity of 92.1%.Conclusions: Cardiac injury complicates the disease course and increases the mortality rate of COVID-19. Troponin levels should be checked at admission and during hospitalization for triage, better monitoring, and managing those with COVID-19, especially in the most severe patients.Condensed Cardiac injury is not uncommon in COVID-19. In a cohort of 222 patients with COVID-19, cardiac injury was found in 29 patients on admission and in another 6 patients during hospitalization. The admission level of troponin was well-correlated with inflammatory factors and D-dimer levels and strongly predicted mortality. Cardiac injury is a manifestation secondary to hypoxia and systemic infection, but which nevertheless further complicates the disease course and increases the mortality rate. Troponin levels should be checked at admission and during hospitalization for triage, better monitoring, and managing those with COVID-19, especially in the most severe patients.

Cardiac Injury In Patients With Pandemic 2009 Influenza A (H1n1) Infection

Transient Cardiac Injury During H7N9 Infection

Novel Influenza A (H1N1) in Patients with Hematologic Disease

Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected with Avian Influenza A (H7N9) Virus

Cardiac Complications Associated with the Influenza Viruses A Subtype H7N9 or Pandemic H1N1 in Critically Ill Patients under Intensive Care

Fulminant myocarditis in an adult with 2009 pandemic influenza A (H1N1 influenza) infection

The Influence of Influenza A (h1n1) Virus on Creatinine and Cystatin C

Risk Factors for Adult Death Due to 2009 Pandemic Influenza A (H1N1) Virus Infection: a 2151 Severe and Critical Cases Analysis.

Cardiac Injury and Clinical Course of Patients With Coronavirus Disease 2019

Pandemic 2009 Influenza A (h1n1)‐associated Deaths among Children in China: A Retrospective Analysis

Cardiac Injuries in Patients with Coronavirus Disease 2019: Not to Be Ignored

Clinical Features of Pneumonia Caused by 2009 Influenza A(H1N1) Virus in Beijing, China

Clinical findings in 111 cases of influenza A (H7N9) virus infection.

Clinical characteristics of critical patients with pandemic influenza A (H1N1) virus infection in Chengdu, China

The need for strengthening the influenza virus detection ability of hospital clinical laboratories: an investigation of the 2009 pandemic

Clinical Study on Serum Myocardial Enzymes in Patients with H1N1 Influenza A Virus Infection

Abstract 15633: Clinical Features and Prognosis of Acute Cardiac Injury in Hospitalized Patients With Covid-19: A Retrospective Cohort Study

Central Contributions of Myocardial Injury to Adverse Outcomes in Patients with Coronavirus Disease 2019

Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19)

Acute Myocardial Injury of Patients with Coronavirus Disease 2019

Cardiac injuries in coronavirus disease 2019 (COVID-19)